Registry of biomarkers in heart valve disease
A Registry Study of Biomarkers in Heart Valve Disease
This study is trying to find specific markers in the blood that can help us understand heart valve disease better, especially in older adults with conditions like Aortic Stenosis and Mitral Regurgitation.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200000 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Beijing Institute of Heart, Lung and Blood Vessel Diseases Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Trial ID | NCT06223906 on ClinicalTrials.gov |
What this trial studies
This observational study aims to identify biomarkers associated with heart valve disease, particularly focusing on conditions like Aortic Stenosis and Mitral Regurgitation, which significantly affect the elderly population. By utilizing multi-omics approaches, the study seeks to enhance the understanding of the pathophysiology of valvular heart disease, which is currently poorly understood. The research will involve patients diagnosed with heart valve disease at Beijing Anzhen Hospital, collecting medical records and ultrasound data for analysis.
Who should consider this trial
Good fit: Ideal candidates for this study are patients clinically diagnosed with heart valve disease who are receiving care at Beijing Anzhen Hospital.
Not a fit: Patients under 18 years of age or those unable to provide necessary medical records and ultrasound data will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies and outcomes for patients with heart valve disease.
How similar studies have performed: While the study's approach is novel in its focus on multi-omics biomarkers for heart valve disease, similar studies in other cardiovascular conditions have shown promise in identifying relevant biomarkers.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients clinically diagnosed with heart valve disease in Beijing Anzhen Hospital Exclusion Criteria: * Age \< 18 years * Failure to obtain medical records and ultrasound data * Refuse follow-up
Where this trial is running
Beijing, Beijing Municipality
- Beijing Anzhen Hospital — Beijing, Beijing Municipality, China (Recruiting)
Study contacts
- Study coordinator: Yuan Wang, Dr
- Email: wangyuan980510@163.com
- Phone: 13910161443
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.